Incyte Corporation (INCY)

Current ratio

Dec 31, 2024 Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019
Total current assets US$ in thousands 3,239,030 2,808,710 4,849,090 4,645,400 4,402,660 4,264,430 3,971,630 4,092,850 3,821,110 3,625,840 3,288,090 3,118,670 2,923,800 2,620,060 2,449,970 2,359,890 2,159,420 2,077,620 1,716,170 2,481,490
Total current liabilities US$ in thousands 1,641,850 1,501,650 1,396,450 1,240,380 1,124,680 1,118,770 1,006,110 1,157,080 1,006,600 926,674 886,163 854,308 742,712 660,324 623,881 631,195 606,202 556,513 503,412 513,340
Current ratio 1.97 1.87 3.47 3.75 3.91 3.81 3.95 3.54 3.80 3.91 3.71 3.65 3.94 3.97 3.93 3.74 3.56 3.73 3.41 4.83

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $3,239,030K ÷ $1,641,850K
= 1.97

The current ratio of Incyte Corporation has exhibited a relatively stable trend over the analyzed periods, fluctuating within a range of 1.87 to 4.83. The current ratio measures the company's ability to meet its short-term obligations with its current assets. From December 31, 2019, to September 30, 2024, the current ratio decreased gradually before experiencing a notable decline from 3.47 on March 31, 2024, to 1.87 on September 30, 2024. This decline may indicate a potential liquidity concern as the company's short-term assets may not be sufficient to cover its short-term liabilities adequately. Further monitoring of the current ratio will be essential to assess Incyte Corporation's liquidity position and financial health.